• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种糖苷酶的共同抗原性。

Common antigenicity for two glycosidases.

作者信息

Kakavanos Revecca, Lehn Pierre, Callebaut Isabelle, Meikle Peter J, Parkinson-Lawrence Emma J, Hopwood John J, Brooks Doug A

机构信息

Lysosomal Diseases Research Unit, Department of Genetic Medicine, Children Youth and Women's Health Service, 72 King William Road, North Adelaide, Adelaide, SA 5006, Australia.

出版信息

FEBS Lett. 2006 Jan 9;580(1):87-92. doi: 10.1016/j.febslet.2005.11.053. Epub 2005 Dec 6.

DOI:10.1016/j.febslet.2005.11.053
PMID:16359666
Abstract

Enzyme replacement therapy (ERT) has proven to be an effective therapy for some lysosomal storage disorder (LSD) patients. A potential complication during ERT is the generation of an immune response against the replacement protein. We have investigated the antigenicity of two distantly related glycosidases, alpha-glucosidase (Pompe disease or glycogen storage disease type II, GSD II), and alpha-L-iduronidase (Hurler syndrome, mucopolysaccharidosis type I, MPS I). The linear sequence epitope reactivity of affinity purified polyclonal antibodies to recombinant human alpha-glucosidase and alpha-L-iduronidase was defined, to both glycosidases. The polyclonal antibodies exhibited some cross-reactive epitopes on the two proteins. Moreover, a monoclonal antibody to the active site of alpha-glucosidase showed cross-reactivity with a catalytic structural element of alpha-L-iduronidase. In a previous study, in MPS I patients who developed an immune response to ERT, this same site on alpha-L-iduronidase was highly antigenic and the last to tolerise following repeated enzyme infusions. We conclude that glycosidases can exhibit cross-reactive epitopes, and infer that this may relate to common structural elements associated with their active sites.

摘要

酶替代疗法(ERT)已被证明是治疗某些溶酶体贮积症(LSD)患者的有效疗法。ERT期间的一个潜在并发症是产生针对替代蛋白的免疫反应。我们研究了两种远缘糖苷酶的抗原性,即α-葡萄糖苷酶(庞贝病或糖原贮积病II型,GSD II)和α-L-艾杜糖醛酸酶(Hurler综合征,黏多糖贮积症I型,MPS I)。确定了亲和纯化的多克隆抗体对重组人α-葡萄糖苷酶和α-L-艾杜糖醛酸酶的线性序列表位反应性,这两种糖苷酶都有。多克隆抗体在这两种蛋白质上表现出一些交叉反应表位。此外,一种针对α-葡萄糖苷酶活性位点的单克隆抗体与α-L-艾杜糖醛酸酶的一个催化结构元件表现出交叉反应性。在先前的一项研究中,在对ERT产生免疫反应的MPS I患者中,α-L-艾杜糖醛酸酶上的这个相同位点具有高度抗原性,并且在反复输注酶后是最后一个被耐受的位点。我们得出结论,糖苷酶可以表现出交叉反应表位,并推断这可能与与其活性位点相关的共同结构元件有关。

相似文献

1
Common antigenicity for two glycosidases.两种糖苷酶的共同抗原性。
FEBS Lett. 2006 Jan 9;580(1):87-92. doi: 10.1016/j.febslet.2005.11.053. Epub 2005 Dec 6.
2
Enzyme replacement therapy in mucopolysaccharidosis I: altered distribution and targeting of alpha-L-iduronidase in immunized rats.黏多糖贮积症 I 型中的酶替代疗法:免疫大鼠中 α-L-艾杜糖醛酸酶的分布和靶向改变
Mol Genet Metab. 2000 Apr;69(4):277-85. doi: 10.1006/mgme.2000.2979.
3
Immune response to enzyme replacement therapy: 4-sulfatase epitope reactivity of plasma antibodies from MPS VI cats.对酶替代疗法的免疫反应:MPS VI型猫血浆抗体的4-硫酸酯酶表位反应性
Mol Genet Metab. 1999 Jul;67(3):194-205. doi: 10.1006/mgme.1999.2859.
4
Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model.使用新型免疫缺陷型糖原贮积症II型(GSD-II)小鼠模型提高庞贝氏病基因治疗方法的疗效。
Gene Ther. 2004 Nov;11(21):1590-8. doi: 10.1038/sj.gt.3302314.
5
Immune response to enzyme replacement therapy: single epitope control of antigen distribution from circulation.酶替代疗法的免疫反应:循环中抗原分布的单表位控制
Mol Genet Metab. 2002 Sep-Oct;77(1-2):127-35. doi: 10.1016/s1096-7192(02)00148-8.
6
Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease.在庞贝病中,α-葡萄糖苷酶造血干细胞基因转移后对酶替代疗法的部分表型纠正和免疫耐受诱导。
J Gene Med. 2009 Apr;11(4):279-87. doi: 10.1002/jgm.1305.
7
Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I.黏多糖贮积症 I 型患者长期酶替代治疗后的免疫耐受
Lancet. 2003 May 10;361(9369):1608-13. doi: 10.1016/S0140-6736(03)13311-9.
8
Pre-stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous enzyme post-transplant: a case report.黏多糖贮积症I型患者干细胞移植前酶替代疗法不会导致显著抗体形成或移植后内源性酶恢复延迟:病例报告
Pediatr Transplant. 2007 Aug;11(5):563-7. doi: 10.1111/j.1399-3046.2007.00720.x.
9
Enzyme replacement therapy in feline mucopolysaccharidosis I.猫黏多糖贮积症I型的酶替代疗法。
Mol Genet Metab. 2001 Mar;72(3):199-208. doi: 10.1006/mgme.2000.3140.
10
Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease.庞贝病α-葡萄糖苷酶替代治疗并发肾病综合征
Pediatrics. 2004 Oct;114(4):e532-5. doi: 10.1542/peds.2003-0988-L.